KIT and gastrointestinal stromal tumor: Another possible mechanism of imatinib resistance is KIT gene amplification, and other oncogenes and tumor suppressor genes may also be responsible for imatinib resistance in GIST, for example, silencing of the PTEN gene or activation of ERK [2, 36, 37].